appleinsider - Months ahead of the fall launches, and historically right on time, Apple supply chain partner Foxconn has started to hire a small army of assemblers to build the iPhone 18 Pro.Workers at a Foxconn facility - Image source: FoxconnEach summer, the Apple sup…
AI Summary: Agenus has suspended the BATTMAN clinical trial and announced a follow‑on program called ROBBIN after strategic reassessment, a move that has raised questions about transparency and participant communication. The abrupt pivot highlights tensions between rapid corporate decision‑making and the need to maintain patient trust in oncology research.
Nine‑year CheckMate‑214 follow‑up confirms durable immunotherapy benefit / 21 days
Teclistamab shows survival benefit prompting earlier use discussions / 5 wks
CAR-PRISM trial shows BCMA CAR T effective in high-risk smoldering myeloma / 3 months
Long‑term immunotherapy appears safe for alveolar soft part sarcoma / 3 months
Zongertinib emerges as first-line therapy for HER2‑mutant NSCLC / 3 months
New mechanism may explain why many cancer drugs fail / 3 months
Antoni Ribas receives AACR‑Margaret Foti Award for leadership / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.